Officers and Directors
Jim Hitchin, CEO, joined the Company in March 2004 as part of the acquisition team. Previously he was the founder, CEO and Chairman of Infrasonics, Inc., a medical device company in the respiratory care field. The company was the first in its market to have ISO9001 and the CE Mark for fourteen 510(k) and two PMA products. Growth was at a compound rate of 62% during its fifteen-year life before being sold to a competitor. In previous companies, he was COO of a public energy company and the VP, General Manager of a public oceanographic engineering firm. Mr. Hitchin has extensive experience in all phases of manufacturing and company operations. He graduated from San Diego State University with a B.S. degree in Physics.

Honorable Tommy Thompson, Director Before entering the private sector in 2005, Secretary Thompson enjoyed a long and distinguished career in public service. In 1966 he won a seat in Wisconsin’s state Assembly. He became assistant Assembly minority leader in 1973 and Assembly minority leader in 1981. Elected governor of Wisconsin in 1986, he was reelected in 1990, and in 1994 became the first governor in the state’s history to be elected to a third four-year term. In 1998 he was elected to a fourth term, and served in that position until his appointment as Secretary of Health & Human Services in 2001. As the head of the Department of Health & Human Services, Secretary Thompson served as the nation’s leading advocate for the health and welfare of all Americans. He worked to modernize and add prescription drug coverage to Medicare for the first time in the program’s history. A leading advocate of welfare reform, he also focused on expanding services to seniors, the disabled and low-income Americans. As governor of Wisconsin, Secretary Thompson was perhaps best known for his efforts to revitalize the Wisconsin economy, for his national leadership on welfare reform and for his work in expanding health care access across all segments of society. Secretary Thompson is well-known for his contributions to the U.S. response to the threat of bioterrorism and for his leadership in the fight against HIV/AIDS in the United States and abroad; he currently serves as the chairman of the Global Fund to Fight AIDS, Tuberculosis and Malaria. Secretary Thompson has received numerous awards for his public service, including the Anti-Defamation League’s Distinguished Public Service Award, Governing Magazine’s Public Official of the Year Award and the Horatio Alger Award, which is awarded annually to “dedicated community leaders who demonstrate individual initiative and a commitment to excellence—as exemplified by remarkable achievements accomplished through honesty, hard work, self-reliance, and perseverance.” He is a former chairman of the National Governors’ Association, the Education Commission of the States and the Midwestern Governors’ Conference. Secretary Thompson received both his B.S. in 1963 and his J.D. in 1966 from the University of Wisconsin-Madison. He is a member of the District of Columbia and Wisconsin Bars.

Chester E. Sievert, Jr., Director, joined SpectraScience as a consultant in June 1996, and held various executive positions including Chairman of the Board, President and CEO. He is currently President of Advanced Photodynamic Technologies. Prior to SpectraScience, Mr. Sievert was a founder and President at two medical product companies; ReTech, Inc. from 1980 to 1986; and FlexMedics Corporation from 1986 to 1985. Both Companies were sold respectively to American Endoscopy, Inc. and Phillips Plastics Corporation. As a former Senior Research Health Science on staff at the University of Minnesota Medical School and the Veterans Administration Medical Center, Mr. Sievert has published more than 50 medical journal articles in the fields of Gastroenterology, endoscopy and fiber optics. He has also been awarded eight United States and international patents. Mr. Sievert has a Bachelor of Science Degree in Comparative Physiology from the University of Minnesota.

Mark McWilliams, Director, currently serves as Director of Cell Imaging and Analysis at Beckman Coulter after the recent sale of Q3DM to Beckman in December 2003. He was President and Chief Executive Officer and Director of Q3DM, a life -sciences startup that raised several angel and venture capital funding rounds. Previously, he was founder and COO of Medication Delivery Devices (MDD), an alternate care infusion systems company that was acquired by Baxter Healthcare in 1996. Mr. McWilliams served as a VP of Research and Development at Baxter Healthcare for three years following the sale of MDD. Prior to MDD, he served as Product Development Manager at the founding of Block Medical where he was responsible for bringing the company's first two FDA approved products rapidly to market. Block was sold to Hillenbrand Industries in 1991. He previously worked for Hughes Aircraft, Vacuum General and Martin Marietta. He earned his MSME from the Massachusetts Institute of Technology, his BSME from Northeastern University and holds eight utility patents.

Rand P. Mulford, Director, currently, Mr. Mulford serves as EVP for Strategy with Chatham Capital and Forest Health Services. For the previous two years, he was part of the senior management team of a small investment banking firm that specializes in funding early stage companies and technology-based spinouts using private placements. he has worked directly with four portfolio companies. Mr. Mulford was asked to identify critical issues and develop business strategy, serve on three of the Boards of Directors, assume a direct managerial role in two of the companies, and negotiate the successful sale of one of the companies, His corporate experience includes: Group VP of planning and control for a petrochemical company; head of corporate planning at Merck; CFO of a human tissue company; COO of a drug discovery company and president of its subsidiary, a research chemical company; COO of a diagnostics company; Chairman of the Board of a medical device company; and head of the corporate development at a bio-pharmaceutical company. Mr. Mulford started his business career with the consulting firm of McKinsey & Co. in the Chicago office. During an eight-year period, he served about twenty clients working on a variety of issues primarily related to strategy and organization. Mr. Mulford obtained a bachelors degree in engineering with honors from Princeton University in 1965. For the next five years he served as a naval officer in the nuclear submarine program. Subsequently, he earned an MBA with high distinction at Harvard Business School.

Stanley J. Pappelbaum M.D., Director, is Managing Partner of Pappelbaum, Turner & Associates, a national healthcare consultancy company that advises hospital, medical group, health insurance, and governmental healthcare clients. Dr. Pappelbaum joined Scripps hospital in 1996 as Chief Transformational Officer in charge of creating and implementing Scripps’ strategic vision of the future. In 1997, he was promoted to Executive Vice President and Chief Operating Officer and, in 1999, he was promoted to President and Chief Executive Officer when the hospital reached annual revenues of over $1 billion. From 1985 to 1995, he was the managing partner of Professional Health Consulting Group, a national company of physician executives who analyzed and managed change for complex not-for-profit healthcare systems clients throughout the United States. From 1969 to 1984, Dr. Pappelbaum taught and practiced Pediatric Cardiology at the University of California, San Diego and at San Diego Children’s Hospital, where he was Chief of Pediatric Cardiology from 1972-1978. Dr. Pappelbaum completed his undergraduate work at McGill University, Montreal and received his medical degree from the University of British Columbia Faculty of Medicine in Vancouver. He completed his residency in pediatric medicine at Montreal Children’s Hospital of McGill University and did graduate studies in cardiovascular physiology and a fellowship in pediatric cardiology at the University of California, Los Angeles. He also was awarded an Alfred P. Sloan Fellowship at the Massachusetts Institute of Technology where he earned a Master's degree in management (health option) from MIT.

John Pappajohn, Director, has been the President and principal stockholder of Equity Dynamics, Inc., a financial consulting firm, and the sole owner of Pappajohn Capital Resources, a venture capital firm. Mr. Pappajohn has been involved in the development and financing of hundreds of companies during his career and has served as a director of more than 40 public companies. In addition to SpectraScience, Inc., he currently serves as a director of the following public companies; Allion Healthcare, Inc., American CareSource Holdings, Inc., CareGuide, Inc., ConMed Healthcare Management, Inc., and Healthcare Acquisition Corp. Mr. Pappajohn received his B.S.C. from the University of Iowa.

Medical and Scientific Advisory Board
Management and staff consult on different aspects of our scientific research and development programs with members of SpectraScience's Medical and Scientific Advisory Board. The Board is composed of individuals with expertise in various medical specialties who are able to provide advice regarding the development of our products and systems, the design of our clinical trials, regulatory strategies and reimbursement issues. A list of the current members of the Medical and Scientific Advisory Board with brief biographies is set forth below.

Merrill A. Biel, M.D., Ph.D., M.B.A. is President and Staff Physician at Ear, Nose & Throat Specialty Care of Minnesota in Minneapolis, Minnesota. He is an Associate Professor in the Departments of Otolaryngology, Head and Neck Surgery, and Family Practice at the University of Minnesota and is Clinical Professor at the University of Minnesota School of Veterinary Medicine. He is the Director of Photodynamic Therapy at Abbott Northwestern Hospital and is President of Advanced Photodynamic Technologies in Minneapolis. He is a Fellow of the Society of Surgical Oncology, American Society of Head and Neck Surgery, American Society of Clinical Oncology, and the Triologic Society. Dr. Biel received his M.D. degree from the University of Illinois in Chicago, Illinois, his Ph.D. and M.B.A. degrees from the University of Minnesota in Minneapolis, Minnesota.

Douglas M. Hawkins, Ph.D. is a Professor of Statistics and the Chairman of the Department of Applied Statistics at the University of Minnesota. He is a member of the International Statistical Institute, a fellow of the American Statistical Association and a senior member of the American Society for Quality. He is also an associate editor of the Journal for the American Statistical Association. Dr. Hawkins received his Ph.D. degree from the Witwatersrand University, Johannesburg, South Africa, in 1969.

Jose Jessurun, M.D. is an Associate Professor of Pathology at the University of Minnesota and is the Director of Surgical Pathology, Department of Laboratory Medicine and Pathology, at the University of Minnesota. He is a member of the Latin American Society of Pathology, the United States and Canadian Academy of Pathology and the Minnesota Society of Clinical Pathology. Dr. Jessurun received his M.D. degree from the National Autonomous University of Mexico in Mexico City in 1977, was the chief resident in surgical pathology at Massachusetts General Hospital from 1983-84 and has been an Associate Professor at the University of Minnesota since 1991.